The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Umbilical cord‐derived mesenchymal stem cells (UC‐MSCs), with both immunomodulatory and pro‐regenerative properties, are promising for the treatment of type 2 diabetes mellitus (T2DM). As efficient cell therapy largely relies on appropriate homing to target tissues, knowing where and to what extent injected UC‐MSCs have homed is critically important. However, bio‐distribution data for UC‐MSCs in T2DM subjects are extremely limited. Beneficial effects of UC‐MSCs on T2DM subjects are associated with increased M2 macrophages, but no systemic evaluation of M2 macrophages has been performed in T2DM individuals. In this study, we treated T2DM mice with CM‐Dil‐labelled UC‐MSCs. UC‐MSC infusion not only exerted anti‐diabetic effects but also alleviated dyslipidemia and improved liver function in T2DM mice. To compare UC‐MSC migration between T2DM and normal subjects, a collection of normal mice also received UC‐MSC transplantation. UC‐MSCs homed to the lung, liver and spleen in both normal and T2DM recipients. Specifically, the spleen harbored the largest number of UC‐MSCs. Unlike normal mice, a certain number of UC‐MSCs also homed to pancreatic islets in T2DM mice, which suggested that UC‐MSC homing may be closely related to tissue damage. Moreover, the number of M2 macrophages in the islets, liver, fat and muscle significantly increased after UC‐MSC infusion, which implied a strong link between the increased M2 macrophages and the improved condition in T2DM mice. Additionally, an M2 macrophage increase was also observed in the spleen, suggesting that UC‐MSCs might exert systemic effects in T2DM individuals by modulating macrophages in immune organs. HIGHLIGHTSUC‐MSCs homed to the lung, liver and spleen. The spleen harbored the largest number of UC‐MSCs.Unlike normal mice, a certain number of UC‐MSCs homed to pancreatic islets in T2DM mice.UC‐MSC infusion not only exerted anti‐diabetic effects but also alleviated dyslipidemia and improved liver function.UC‐MSCs infusion induced an increase of M2 macrophages in the pancreatic islets, adipose tissue, liver and skeletal muscle.UC‐MSCs infusion induced an increase of M2 macrophages in the spleen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733
Identification of splenic reservoir monocytes and their deployment to inflammatory sites
Swirski, F. K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., Figueiredo, J.-L., Kohler, R. H., Chudnovskiy, A., Waterman, P., et al. (2009) · Science · doi:10.1126/science.1175202 · Cited by 2,221
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107
The cellular and signaling networks linking the immune system and metabolism in disease
Osborn, O., & Olefsky, J. M. (2012) · Nature Medicine · doi:10.1038/nm.2627 · Cited by 1,551
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s055 · Cited by 1,062
Phagocyte partnership during the onset and resolution of inflammation
Soehnlein, O., & Lindbom, L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2779 · Cited by 1,054
Hevener, A. L., Olefsky, J. M., Reichart, D., Nguyen, M. T. A., Bandyopadyhay, G., Leung, H.-Y., Watt, M. J., Benner, C., Febbraio, M. A., Nguyen, A.-K., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31561 · Cited by 459
Cited by
Scaffold-Mediated Immunoengineering as Innovative Strategy for Tendon Regeneration
Russo, V., El Khatib, M., Prencipe, G., Cerveró-Varona, A., Citeroni, M. R., Mauro, A., Berardinelli, P., Faydaver, M., Haidar-Montes, A. A., Turriani, M., et al. (2022) · Cells · doi:10.3390/cells11020266 · Cited by 49
Hu, R., Zhao, J., Cheng, Y., Su, W., Ren, R., Zhang, H., Zhang, Y., Wang, A., Mu, Y., & Yu, S. (2025) · Stem Cells International · doi:10.1155/sci/4639115 · Cited by 7
“Previous literature has indicated that following injection into T2D mice via the tail vein, MSCs can migrate abundantly to the lung, spleen, and liver [37]; thus highlighting their potential ef fi cacy [38] in treating liver diseases, such as NAFLD.”
Self-citationWang, Y., Yu, H., Tang, H., Zhu, R., Shi, Y., Xu, C., Li, Y., Wang, H., Chen, Y., Shen, P., et al. (2023) · Regenerative Therapy · doi:10.1016/j.reth.2023.07.007 · Cited by 3
Metadata
- Authors
- Yin, Y., Hao, H., Cheng, Y., Gao, J., Liu, J., Xie, Z., Zhang, Q., Zang, L., Han, W., & Mu, Y.
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 60
- Pages
- 235-245
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W2804450504
- Cited by
- 61
- References
- 8
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice. https://app.cochat.ai/papers/10.1016/j.intimp.2018.04.051
- The paper
- Yin, Y., Hao, H., Cheng, Y., Gao, J., Liu, J., Xie, Z., Zhang, Q., Zang, L., Han, W., & Mu, Y. (2018). The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2018.04.051
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.